TrialLeukemia2021

A multicenter prospective, randomized, placebo-controlled phase II/III trial for preemptive acute graft-versus-host disease therapy.

Eva M Weissinger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.